Proton Therapy Did Not Help Advanced Liver Cancer Patients Live Longer Than Standard Radiation in Phase 3 Trial
In the Phase 3 NRG-GI003 trial, proton therapy did not extend survival over standard radiation in advanced liver cancer. Here is what patients should ask.
Medical Daily ·